Nykredit Invest Lifts Trading Suspension on Multiple Sub-Funds
Nykredit Invest restores market access for its sub-funds, ending a temporary suspension period and allowing investors to resume trading operations.
Stocks: the latest market news with AI summary, sentiment and the assets affected, updated around the clock.
Nykredit Invest restores market access for its sub-funds, ending a temporary suspension period and allowing investors to resume trading operations.
Nykredit Portfolio Administration A/S confirms the lifting of trading suspensions across its departments, restoring full liquidity and trading capabilities for investors.
Nykredit confirms the resumption of trading for its previously suspended investment departments, restoring full market access for investors.
Actinium Pharmaceuticals strengthens its leadership team with a new business development head to drive strategic licensing and commercial growth in the radiopharmaceutical…
Nykredit confirms the resumption of trading for its previously suspended investment departments, restoring full market access for investors.
Future Mineral Resources secures full ownership of its Polish nickel-zinc-lead project through an amended share purchase agreement, marking a significant consolidation of…
Sparinvest has suspended trading for all sub-funds on Nasdaq Copenhagen due to technical failures preventing the timely reporting of net asset values.
Nykredit Portefølje Administration has restored trading access to its previously suspended investment departments, allowing investors to resume market activity.
Nykredit Portefølje Administration halts trading across all SparDanmark Invest sub-funds on Nasdaq Copenhagen due to technical issues hindering accurate NAV calculations.
Nykredit Portefølje Administration confirms that trading has resumed for previously suspended funds, allowing investors to execute transactions again.
MINISFORUM expands its hardware portfolio with the S5, a fanless 5-bay all-flash NAS powered by Intel's Core 3 304 processor, targeting users…
Sobi's TRYNGOLZA receives positive CHMP recommendation following Phase 3 results showing significant reductions in triglyceride levels and acute pancreatitis risk, paving the…